Cleared Traditional

K911958 - CYTOCLONE A & B EIA

K911958 is an FDA 510(k) clearance for CYTOCLONE A & B EIA, manufactured by Cambridge Biotech Corp.. The device is a Class 1 Microbiology device with product code LLH cleared through the Traditional 510(k) pathway after a 88-day FDA review.

K911958 · Cambridge Biotech Corp. · Microbiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 1991
Decision
88d
Days
Class 1
Risk

K911958 is an FDA 510(k) clearance for the CYTOCLONE A & B EIA. Classified as Reagents, Clostridium Difficile Toxin (product code LLH), Class I - General Controls.

Submitted by Cambridge Biotech Corp. (Worcester, US). The FDA issued a Cleared decision on July 30, 1991 after a review of 88 days - a notably fast clearance cycle.

This device falls under the Microbiology FDA review panel, regulated under 21 CFR 866.2660 - the FDA microbiology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Cambridge Biotech Corp. devices

FDA 510(k) Submission Details - K911958

510(k) Number K911958 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 03, 1991
Decision Date July 30, 1991
Days to Decision 88 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary Statement
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
14d faster than avg
Panel avg: 102d · This submission: 88d
Pathway characteristics
Predicate-based equivalence.

LLH Device Classification - Class 1, General Controls

Product Code LLH Reagents, Clostridium Difficile Toxin
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 866.2660
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - LLH Reagents, Clostridium Difficile Toxin

All 35
Devices cleared under the same product code (LLH) and FDA review panel - the closest regulatory comparables to K911958.
CLOSTRIDIUM DIFFICILE TOX-A-TEST
K914902 · Techlab, Inc. · Mar 1992
VIDAS CLOSTRIDIUM DIFFICILE TOXIN A (CDA) ASSAY
K905211 · Vitek Systems, Inc. · Oct 1991
BARTELS CLOSTRIDIUM DIFFICILE TOXIN A ENZYM IMMUN
K913229 · Baxter Diagnostics, Inc. · Aug 1991
PREMIER-C. DIFFICILE TOXIN A
K903456 · Meridian Diagnostics, Inc. · Oct 1990
CDT CYTOTOXI TEST
K883560 · Advanced Clinical Diagnostics · Oct 1988
CULTURETTE BRAND CDT CLOSTRIDIUM DIFFICILE TEST
K870864 · Marion Laboratories, Inc. · Apr 1987